RBC Europe’s Pediatrix Medical MD Stock Holding History

RBC Europe’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,100	Closed	-$36.3K	–	1096
2018 Q4	$36.3K	Hold	1,100	–	–	﹤0.01%	505
2018 Q3	$51.3K	Buy	+1,100	New	+$50.5K	0.01%	468

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RBC Europe's MD Position: Q1 2019 in Review

RBC Europe sold out of Pediatrix Medical (MD) in Q1 2019, closing a stake of 1,100 shares — an estimated $36.3K sold.

RBC Europe first reported a position in MD in Q3 2018 and held it in 2 quarters. The position peaked at $51.3K in Q3 2018. 297 funds tracked by Wall St. Rank hold MD as of Q1 2019.

RBC Europe reported no remaining Pediatrix Medical position as of Q1 2019 after selling out during the quarter.
RBC Europe sold 1,100 Pediatrix Medical shares in Q1 2019, an estimated $36.3K.
RBC Europe first reported a position in Pediatrix Medical in Q3 2018 and held it in 2 quarters.
RBC Europe's Pediatrix Medical position peaked at $51.3K in Q3 2018.
297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2019.

Based on RBC Europe's 13F filing for Q1 2019, filed 9 Nov 2023.